1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Adler, M. Seto, M. Nitecki, D. Light, D.R. Morser, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 270 23366 23372 10.1074/jbc.270.40.23366 7559494 The structure of a 19-residue fragment from the C-loop of the fourth epidermal growth factor-like domain of thrombomodulin. 1995 10.2210/pdb1tmr/pdb pdb_00001tmr 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2073.396 THROMBOMODULIN PRECURSOR 1 man polymer no no VCAEGFAPIPGEPHRCQLF VCAEGFAPIPGEPHRCQLF A polypeptide(L) n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1995-06-08 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1994-05-20 REL 10 BIOSYM,INC. refinement DGII VAL 1 n 1 VAL 1 A CYS 2 n 2 CYS 2 A ALA 3 n 3 ALA 3 A GLU 4 n 4 GLU 4 A GLY 5 n 5 GLY 5 A PHE 6 n 6 PHE 6 A ALA 7 n 7 ALA 7 A PRO 8 n 8 PRO 8 A ILE 9 n 9 ILE 9 A PRO 10 n 10 PRO 10 A GLY 11 n 11 GLY 11 A GLU 12 n 12 GLU 12 A PRO 13 n 13 PRO 13 A HIS 14 n 14 HIS 14 A ARG 15 n 15 ARG 15 A CYS 16 n 16 CYS 16 A GLN 17 n 17 GLN 17 A LEU 18 n 18 LEU 18 A PHE 19 n 19 PHE 19 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 8.40 1.30 111.50 119.90 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 1 4.54 0.50 120.30 124.84 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 2 8.39 1.30 111.50 119.89 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 2 4.57 0.50 120.30 124.87 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 3 8.42 1.30 111.50 119.92 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 3 4.53 0.50 120.30 124.83 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 4 8.47 1.30 111.50 119.97 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 4 4.51 0.50 120.30 124.81 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 5 8.44 1.30 111.50 119.94 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 5 4.54 0.50 120.30 124.84 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 6 8.50 1.30 111.50 120.00 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 6 4.56 0.50 120.30 124.86 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 7 8.46 1.30 111.50 119.96 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 7 4.57 0.50 120.30 124.87 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 8 8.43 1.30 111.50 119.93 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 8 4.62 0.50 120.30 124.92 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 9 8.49 1.30 111.50 119.99 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 9 4.56 0.50 120.30 124.86 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 10 8.43 1.30 111.50 119.93 A A A ND1 CE1 NE2 HIS HIS HIS 14 14 14 N 10 4.56 0.50 120.30 124.86 A A A NE CZ NH1 ARG ARG ARG 15 15 15 N 1 A A CD OE2 GLU GLU 4 4 0.108 0.011 1.252 1.360 N 1 A A CD OE2 GLU GLU 12 12 0.112 0.011 1.252 1.364 N 2 A A CD OE2 GLU GLU 4 4 0.109 0.011 1.252 1.361 N 2 A A CD OE2 GLU GLU 12 12 0.112 0.011 1.252 1.364 N 3 A A CD OE2 GLU GLU 4 4 0.108 0.011 1.252 1.360 N 3 A A CD OE2 GLU GLU 12 12 0.112 0.011 1.252 1.364 N 4 A A CD OE2 GLU GLU 4 4 0.107 0.011 1.252 1.359 N 4 A A CD OE2 GLU GLU 12 12 0.111 0.011 1.252 1.363 N 4 A A CG CD2 HIS HIS 14 14 0.055 0.009 1.354 1.409 N 5 A A CD OE2 GLU GLU 4 4 0.108 0.011 1.252 1.360 N 5 A A CD OE2 GLU GLU 12 12 0.113 0.011 1.252 1.365 N 6 A A CD OE2 GLU GLU 4 4 0.107 0.011 1.252 1.359 N 6 A A CD OE2 GLU GLU 12 12 0.112 0.011 1.252 1.364 N 7 A A CD OE2 GLU GLU 4 4 0.108 0.011 1.252 1.360 N 7 A A CD OE2 GLU GLU 12 12 0.111 0.011 1.252 1.363 N 8 A A CD OE2 GLU GLU 4 4 0.108 0.011 1.252 1.360 N 8 A A CD OE2 GLU GLU 12 12 0.111 0.011 1.252 1.363 N 9 A A CD OE2 GLU GLU 4 4 0.107 0.011 1.252 1.359 N 9 A A CD OE2 GLU GLU 12 12 0.113 0.011 1.252 1.365 N 10 A A CD OE2 GLU GLU 4 4 0.110 0.011 1.252 1.362 N 10 A A CD OE2 GLU GLU 12 12 0.112 0.011 1.252 1.364 N 10 A A CG CD2 HIS HIS 14 14 0.055 0.009 1.354 1.409 N 1 A CYS 2 -166.55 -124.51 1 A ALA 7 174.22 165.84 1 A PRO 8 -54.85 176.76 1 A PRO 10 -63.33 98.64 1 A PRO 13 -87.58 37.30 1 A CYS 16 -102.36 -160.66 1 A GLN 17 -168.53 -134.26 2 A CYS 2 -165.58 -97.59 2 A GLU 4 -68.50 94.39 2 A PRO 8 -56.74 178.41 2 A PRO 13 -79.96 31.84 2 A ARG 15 -120.75 -168.15 2 A GLN 17 -159.44 -135.36 3 A CYS 2 -93.31 -86.87 3 A PRO 8 -63.52 -160.18 3 A PRO 13 -87.51 43.97 3 A GLN 17 -178.21 -132.50 4 A CYS 2 69.82 -94.31 4 A PRO 8 -60.60 -175.91 4 A PRO 13 -82.35 30.03 4 A GLN 17 -132.83 -146.75 5 A CYS 2 78.79 -89.71 5 A ALA 3 169.49 147.67 5 A PRO 8 -57.07 178.13 5 A PRO 13 -80.25 31.70 5 A GLN 17 -141.41 -146.23 6 A CYS 2 50.65 -98.51 6 A ALA 3 169.04 158.48 6 A PRO 13 -84.69 39.08 6 A CYS 16 -103.45 -169.43 6 A GLN 17 -175.04 -125.12 7 A CYS 2 -169.29 -96.92 7 A GLU 4 -69.04 89.91 7 A PRO 8 -55.41 176.74 7 A PRO 13 -84.81 37.38 7 A GLN 17 -82.77 -141.61 8 A CYS 2 -159.79 -85.76 8 A PRO 8 -55.72 173.99 8 A PRO 13 -77.89 29.80 8 A GLN 17 -112.40 -122.72 9 A CYS 2 43.71 -108.85 9 A ALA 3 168.41 132.22 9 A GLU 4 -55.16 93.06 9 A PRO 8 -62.89 -173.74 9 A PRO 13 -87.48 39.63 9 A CYS 16 -88.96 -157.67 9 A GLN 17 -171.44 -57.97 10 A CYS 2 52.33 -94.48 10 A PRO 8 -61.64 -178.12 10 A PRO 13 -85.88 37.06 10 A GLN 17 -147.86 -52.55 THE STRUCTURE OF A 19 RESIDUE FRAGMENT FROM THE C-LOOP OF THE FOURTH EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF THROMBOMODULIN 1 Y N disulf 2.064 A CYS 2 A SG CYS 2 1_555 A CYS 16 A SG CYS 16 1_555 BLOOD COAGULATION BLOOD COAGULATION TRBM_HUMAN UNP 1 1 P07204 MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGG VGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEV KADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAP GAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQ HRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHE PHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDC DSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKE VVLQHVRTERTPQRL 389 407 1TMR 1 19 P07204 A 1 1 19 1 HIS conflict GLY 11 1TMR A P07204 UNP 399 11 1 MET conflict LEU 18 1TMR A P07204 UNP 406 18 1 P 1